Metablue planning to raise EUR 250,000 via crowdfunding for development of clinical trials and first production batches of Otitest
|
20 AUG 2025
|
Intel ID : 421824
|
||||
| Intel ID | 421824 | |
| Value | EUR 0,25m | |
| Native Currency | Euro (EUR) | |
|
Financial Data - Metablue
(31 Dec 2022) |
Revenue: EUR 0,03m EBITDA: EUR 0,02m Net Debt: EUR 0,12m People: 2 |
|
| Date |
 |
|
| Country | |
|
| Geography | |
|
| Subsector (Old TTR Sectors) |
|
|
| Primary Subsector (TTRSC) |
30.02.01 Diagnostic & Testing Substances (Primary) 30 Healthcare / 30.02 Healthcare Equipment & Supplies |
|
| Type |
 |
|
| Intel Grade |
|
|
| Source |
|
|
| Tags | |
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.